HIV / AIDS in the News

Window of Knowledge HIV/AIDS gathers scientific evidence - paho.org

 

CDC funding shift puts $450K in Twin Cities HIV prevention at risk, group says - 5 EYEWITNESS NEWS

 

Unitaid strengthens African manufacturing capacity for next-generation HIV prevention medicines - Unitaid

 

World’s First Monthly Oral HIV Pill Moves Closer With Aspen Deal - Bloomberg.com

 

New Pennsylvania law will decriminalize HIV felony charge in prostitution cases - local21news.com

 

America’s 250th: Reflecting on Progress Against HIV - HIV.gov

 

Merck licenses experimental HIV pill to generic makers in 129 countries - Reuters

 

Merck stages expanded access to monthly HIV PrEP pill ahead of approval - Fierce Pharma

 

3 Facts About the Response to HIV/AIDS in Brunei - The Borgen Project

 

African Union Pushes for Greater Domestic Spending on Health Amid Reports of Huge Disruptions to HIV Services - Health Policy Watch

 

UNFPA at AIDS 2026: The 26th International AIDS Conference - United Nations Population Fund

 

Novo asks court to block Lilly ads; Merck strikes HIV PrEP deal - Endpoints News

 

Merck expands access to alimatravir, generic drug for HIV treatment, to low- and middle-income countries - PharmaLive

 

CDC to cut off $450K in HIV prevention funds in Minneapolis - kare11.com

 

Merck & Co unveils early access strategy for once-monthly HIV prevention pill - The Pharma Letter

 

Pharmalittle: We're reading about an FDA panel and peptides, a Merck license for an HIV pill, and more - STAT

 

Announcing the NIH ARISE-HIV LAUNCH Challenge - POZ

 

MINNEAPOLIMEDIA HEALTH NEWS | Aliveness Project Losing $450,000 in Annual Federal HIV-Prevention Funding - MinneapoliMedia

 

‘Playing with fire’: Trump administration cuts HIV prevention funding to community-based organizations, including Equitas Health in Ohio - The Buckeye Flame

 

EATG at AIDS 2026 - European AIDS Treatment Group

 

Study finds that Trump’s funding cuts led to closing 1,700 HIV treatment sites - Erasing 76 Crimes

 

Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill - STAT

 

Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development - Business Wire

 

Nanopore-based HIV test aims to bring earlier diagnosis into the home - Wiley Analytical Science

 

Twice-Yearly Lenacapavir Strengthens Promise of HIV Prevention - allAfrica.com

 

With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access - The New York Times

 

'I had dreams': How HIV care has evolved across a generation - GSK

 

This drug could help end the HIV epidemic. Its rollout has hit speed bumps - Science | AAAS

 

America’s 250th: Reflecting on Progress Against HIV - HIV.gov

 

Targeting CD4 to Treat HIV - Infectious Disease Special Edition